Interesting Article from MDLinx

k has forwarded you an article from MDLinx Ophthalmology, part of the MDLinx network MDLinx  Ophthalmology 5 minutes to stay current Your Article Summary Combining ROPtool measurements of vascular tortuosity and width to quantify plus disease in retinopathy of prematurity Journal of American Association for Pediatric Ophthalmology and Strabismus , 03/24/11 Cabrera MT et al. – When combining ROPtool's measures of width and tortuosity, sum of adjusted indices, tortuosity–weighted plus, and regression analysis methods had high overall accuracy. ROPtool can now generate a clinically meaningful quantitative description of vascular abnormality to aid in plus disease diagnosis. Receive more summaries like this by joining MDLinx. We provide free daily digests of top journal articles in your field. >> Click here to choose your specialties. Other articles in Ophthalmology >> Click here to see the complete list A New Risk-Based Screening Criterion for Treatment-Demanding Retinopathy of Prematurity in Denmark Pediatrics, 03/04/11 Current update on retinopathy of prematurity: screening and treatment Current Opinion in Pediatrics, 03/23/11 Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity New England Journal of Medicine, 03/09/11 ©1999-2011 MDLinx, Inc. This email was sent at the request of k ©2011 MDLinx, a division of M3 USA M3 USA considers the privacy of its users to be of utmost importance and works to protect it. M3 USA uses personal user information for internal purposes only. We will not sell or share your information with outsiders. For comprehensive information about the steps that M3 USA takes to respect your privacy please read our Privacy Policy . This email has been sent by MDLinx, a division of M3 USA, 1215 17th Street NW, Washington, DC 20036 Tel: +1.202.293.2288 Fax: +1.202.293.1690